BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:America/Vancouver
X-WR-TIMEZONE:America/Vancouver
BEGIN:VEVENT
UID:1-16242@events.ufv.ca
DTSTART;TZID=America/Vancouver:20210324T131500
DTEND;TZID=America/Vancouver:20210324T141500
DTSTAMP:20210322T184127Z
URL:https://events.ufv.ca/events/venturing-into-biotechnology-hosted-by-ef
 cie/
SUMMARY:Venturing into Biotechnology (Hosted by EFCIE)
DESCRIPTION:\nVenturing into Biotechnology (Hosted by EFCIE)\nStarting any 
 new venture as an entrepreneur is challenging\, however there are some uni
 que considerations for a start-up or spin-off in biotech. This presentatio
 n will describe the process of evaluating a new idea or technology and the
  formation of a new company\, aspects that are specific to biotech develop
 ment including the time and capital typically needed to get to a commercia
 l product\, how far the founder is going to take this towards that goal as
  the company scales up\, and some of the difficult decisions to be made al
 ong the way. Strategies for managing risks will be discussed\, along with 
 practical advice for finding support\, mentors\, and ideally investors to 
 enable your vision to become a viable company going forward.\nRegister tod
 ay!\n\n\nMichael Parr\, Ph.D.\n\nPresident and Chief Scientific Officer @S
 itka Biopharma\n\nMichael Parr is the President and Chief Scientific Offic
 er of Sitka Biopharma. With more than 15 years of experience in the indust
 ry\, Dr. Parr has played a key role in developing and guiding a number of 
 programs into clinical trials. Prior to founding Sitka\, Dr. Parr spent 6 
 years as the Director for Commercial Project Development at CDRD Ventures 
 Inc. (CVI)\, where he was responsible for developing and managing the CVI 
 portfolio. From 2006-2008\, he served as Program Manager at Angiotech Phar
 maceuticals\, guiding two late-stage novel biomaterial-based drug products
  in oncology and pain indications toward IND submissions. Previously\, Dr.
  Parr served in a variety of roles of increasing responsibility during his
  7 years at Biogen-Idec\, most recently as Associate Director of Oncology.
  Dr. Parr earned a PhD in Biochemistry and Molecular Biology from the Univ
 ersity of British Columbia and completed post-doctoral training at Harvard
  University.
CATEGORIES:*_UFV Events,Research Events
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Vancouver
X-LIC-LOCATION:America/Vancouver
BEGIN:DAYLIGHT
DTSTART:20210314T030000
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
END:DAYLIGHT
END:VTIMEZONE
END:VCALENDAR